ARTICLE | Company News
Stressgen other research news
January 17, 1994 8:00 AM UTC
SSB (Victoria, B.C.) received C$323,675 from the Canadian federal government to develop technology using bacterial stress proteins as vaccine components.
The funding, which is allocated through the National Research Council's Industrial Research Assistance Program, will be matched by the company over the course of the two-year project. ...